Tandem Diabetes Care Inc (NASDAQ: TNDM) has seen a rise in its stock price by 10.21 in relation to its previous close of 31.73. However,
Additionally, the 36-month beta value for TNDM is 1.15. There are mixed opinions on the stock, with 0 analysts rating it as a “buy,” 1
Company’s 36-month beta value is 1.13.Analysts have differing opinions on the stock, with 0 analysts rating it as a “buy,” 1 as “overweight,” 5 as
Tandem Diabetes Care Inc (NASDAQ: TNDM)’s stock price has dropped by -1.03 in relation to previous closing price of 33.85. Nevertheless, the company has seen
Additionally, the 36-month beta value for TNDM is 1.09. There are mixed opinions on the stock, with 0 analysts rating it as a “buy,” 1
© 2024, Fueled by Smart TechOne
